Trademark Search in Canada

INVEGA

View On IC.GC.CA

REGISTERED

on 4 Dec 2007

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

JOHNSON & JOHNSON A LEGAL ENTITY

One Johnson & Johnson PlazaNew Brunswick, N.J.08933-7001

Serial Number

1279997 filed on 17^th Nov 2005

Registration Number

TMA702213 registered on 4^th Dec 2007

Registration expiry Date

4^th Dec 2032

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

K1P1C3

INVEGA

Trademark usage description

human pharmaceuticals for cancer; anti-inflammatories, autoimmune and dermatological diseases, namely for the treatment of dermatosis, for the treatme Read More

Classification Information

Class [005]
Human pharmaceuticals for cancer; anti-inflammatories, autoimmune and dermatological diseases, namely for the treatment of dermatosis, for the treatment of dandruff, for the treatment of psoriasis, for the treatment of rosacea, for the treatment of skin inflammation, for the treatment of itching, for the treatment of acne and topically administered metroniadazole, medicated shampoos, antibiotic preparations; and central nervous system diseases, namely, encephalitis, epilepsy, cerebral palsy, Alzheimers, Parkinsons disease and schizophrenia.

Classification kind code

Mark Details

Serial Number

1279997

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 50 on 25^th May 2007	Allowed
Submitted for opposition 51 on 25^th May 2007	Allowance Notice Sent
Submitted for opposition 42 on 7^th Mar 2007	Advertised
Submitted for opposition 26 on 31^st Jan 2007	Approved
Submitted for opposition 15 on 22^nd Nov 2006	Correspondence Created
Submitted for opposition 22 on 1^st Jun 2006	Search Recorded
Submitted for opposition 20 on 1^st Jun 2006	Examiner's First Report
Submitted for opposition 1 on 18^th Nov 2005	Created
Submitted for opposition 31 on 18^th Nov 2005	Formalized
Submitted for opposition 30 on 17^th Nov 2005	Filed